NCT07367568 Costotransverse Foramen Block With Erector Spinae Plane Block in Modified Radical Mastectomy
| NCT ID | NCT07367568 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Cancer Institute, Egypt |
| Condition | Costotransverse Foramen Block |
| Study Type | INTERVENTIONAL |
| Enrollment | 110 participants |
| Start Date | 2026-01-24 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 110 participants in total. It began in 2026-01-24 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the costotransverse foramen block with erector spinae plane block in modified radical mastectomy.
Eligibility Criteria
Inclusion Criteria: * Adult females \> 18 years and ≤ 65 years old. * American Society of Anesthesiologists (ASA) physical status П-III. * Body mass index (BMI) 18-35 kg/m2. * Scheduled for modified radical mastectomy. Exclusion Criteria: * Known allergy or hypersensitivity to local anesthetic agents. * Active infection at the injection site (e.g., cellulitis, abscess). * Coagulopathy or ongoing anticoagulant/antiplatelet therapy \[International Normalized Ratio (INR) \> 1.5 or platelet count \< 100,000/µL\]. * Severe respiratory, cardiac, hepatic, or renal disease. * Morbid obesity. * Severe cognitive impairment or uncooperative behavior that could interfere with block placement.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07367568 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 65 Years, studying Costotransverse Foramen Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07367568 currently recruiting?
Yes, NCT07367568 is actively recruiting participants. Contact the research team at mai.elrawas@nci.cu.edu.eg for enrollment information.
Where is the NCT07367568 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07367568 clinical trial?
NCT07367568 is sponsored by National Cancer Institute, Egypt. The trial plans to enroll 110 participants.